A joint venture of
Vivekanand Medical Foundation and Research Centre, Latur
&
Optimus Oncology Pvt. Ltd. India
A Tertiary Cancer Care Center
(Status granted by Govt. of India)
Plot No. 55, Opposite Ford Showroom,
MIDC, Latur. (Maharashtra)
Tel: 02382 - 221920
Monaco-5 Treatment Planning System
Excellence and innovation are the hallmarks of the GammaMed™ name in high dose rate (HDR) brachytherapy. For 50 years, GammaMed products have forged a legacy of firsts, driving technology forward to provide cancer centers worldwide with the most advanced tools for planning and administering brachytherapy treatments. The GammaMedplus iX is the fifth generation in a long and respected line of GammaMed afterloaders.
Radiation Oncologist
Varian
Gamma Med Plus iX 24 Channel Brachytherapy
Radiation Oncologist
Dr. Lalitha Nellore
Medical Oncologist
oncoPathologists
Elekta VMAT
Surgical Oncologist
Team of oncologists
Vivekanad Hospital and research centre ; First established in 1966, is the largest hospital in the city of Latur. It is a 300 bed hospital facility with a staff of 40 panel doctors and 300 paramedical staff.
Vivekanand Cancer Hospital Latur ( VCHL): built over an area of 2 acres, is an elegant stand alone centre 4 Km away from the main hospital and is fully equipped with oncology related facilities. State of the art operation theatres and ICU's are being constructed. Currently there are 3 radiation bunkers in which India's Indigenous tele cobalt therapy ( Bhabhatron-II) unit, Elekta Precise Digital Linear Accelerator and Varian Brachytherapy is installed respectively. Currently 90-100 patients daily receive Radiotherapy at this centre. On an average there are 60-65 oncosurgeries performed by the 2 onco-surgeons per month at the main hospital.
Government Of India has recently assigned tertiary cancer care centre (TCCC) status to Vivekanand cancer hospital and is equipped with most advanced machinery like 3 Tesla MRI, wide bore CT scan, PET CT and other advanced diagnostic and Laboratory equipment.
Optimus Oncology Advanced Radiotherapy Centre at Vivekanand Cancer Hospital, Latur is Equipped with State of the art Multi Energy Linear Accelerator from Elekta and is capable of doing all advanced forms of radiotherapy such as 3DCRT (3 Dimentional Conformal Radiotherapy), IMRT (Intensity Modulated Radiotherapy), VMAT ( Volumetric Modulated Arc Therapy ) & IGRT (Image Guided Radiotherapy)
Varian Gamma Med Plus iX 24 Channel Brachytherapy
PEH-2018-0660
Most importantly, compared to other commercial arc therapy techniques, Elekta VMAT provides the oncologist with the freedom to choose how the optimal dose will be delivered. This is achieved through the unique flexibility of Elekta treatment systems to simultaneously apply digital control to all treatment parameters, allowing doctors to manipulate the radiation dose and the imaging dose.
VMAT provides high dose conformance to the target, while reducing risk to critical structures
VMAT optimizes target dose delivery for all different patients and pathologies
VMAT can reduce treatment time which can also decrease the likelihood of patient movement
VMAT increases patient throughput due to faster delivery times, resulting in reduced waiting lists
Radiation Oncologist
Surgical Oncologist
Elekta Precise Digital linear Accelerator
Dr. Nikhil Ghadyalpatil
Dr. Brijmohan Zanwar
CIN: U74999MH2016PTC285794
Dr. Ajay Punpale
Elekta VMAT, Elekta’s advanced arc therapy technique, establishes new standards for radiation therapy treatment speed and dose reduction to the patient. With Elekta VMAT, single or multiple radiation beams sweep in uninterrupted arc(s) around the patient, dramatically speeding treatment delivery. Clinicians can use Elekta VMAT with complete or partial arc(s) to reduce treatment times from the 8-12 minutes required for conventional radiation therapy to as few as two minutes.
3D volume imaging technology integrated into Elekta treatment systems increases the precision of Elekta VMAT. Physicians can visualize the tumor target at the time of treatment and guide therapy that increases radiation dose to the target while reducing exposure to surrounding healthy tissues.